BFRI

Biofrontera Inc. [BFRI] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

BFRI Stock Summary

Top 10 Correlated ETFs

BFRI

Top 10 Correlated Stocks

BFRI

In the News

BFRI Financial details

Company Rating
-
Market Cap
10.64M
Income
-20.13M
Revenue
34.06M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
83
Optionable
No
Shortable
Yes
Earnings
12 May 2024
P/E
-0.13
Forward P/E
-
PEG
-0
P/S
0.11
P/B
3.23
P/C
-
P/FCF
-0.15
Quick Ratio
0.46
Current Ratio
1.02
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-15.82
EPS next Y
-
EPS next Q
-
EPS this Y
2034.43%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-6.37%
Revenue last 5Y
5.41%
Revenue Q/Q
19.34%
EPS Q/Q
-135.56%
-
-
-
-
SMA20
-19.8%
SMA50
-18.18%
SMA100
-10.99%
Inst Own
-
Inst Trans
-
ROA
-78%
ROE
-217%
ROC
-4.89%
Gross Margin
49%
Oper. Margin
-72%
Profit Margin
-79%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.61-13.42
52W High
-
52W Low
-
RSI
42.51
Rel Volume
0.07
Avg Volume
802.19K
Volume
52.38K
Perf Week
2.65%
Perf Month
-23.87%
Perf Quarter
27.08%
Perf Half Y
25.63%
-
-
-
-
Beta
0.838
-
-
Volatility
0.01%, 0.12%
Prev Close
0.21%
Price
0.8146
Change
1.08%

Something similar

Top by Market Cap
0YXG.L
VTSAX
NVDA
ABEA.DE
AMZN
Top Correlated ETFs
HYDR
SATO
BITS
FIG
FDNI
Top Correlated Stocks
KXIN
INVZ
HIVE
GWRS
NSYS
Similar Market Cap
ZEV
KRKR
MKGI
JJCTF
GAG.DE

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 802.19K
  • Market Capitalization 10.64M
  • Employee 83
  • CEO Dr. Hermann Luebbert Ph.D.
  • Headquarters Woburn,MA,US
  • IPO Date 2021-10-29
  • Website https://www.biofrontera.us.com

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.